Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for VYGR

Stock NameVoyager Therapeutics Inc
TickerVYGR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92915B1061
LEI54930082S4XVR0ZWCC74

Show aggregate VYGR holdings

News associated with VYGR

HC Wainwright Reiterates “Buy” Rating for Voyager Therapeutics (NASDAQ:VYGR)
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $30.00 target price on the stock. Separately, Wedbush lowered their price objective on Voyager Therapeutics from $9.00 to $8.00 and set an “outperform” rating […] - 2025-09-17 02:30:53
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of “Buy” from Brokerages
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have been given an average rating of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12-month […] - 2025-07-30 02:46:52
Brokerages Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are presently covering the company, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […] - 2025-07-08 02:38:54
Voyager Therapeutics (NASDAQ:VYGR) and Prime Medicine (NYSE:PRME) Head-To-Head Contrast
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report) and Prime Medicine (NYSE:PRME – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends and valuation. Institutional and Insider Ownership 48.0% of Voyager […] - 2025-06-18 02:26:52
Analysts Set Voyager Therapeutics, Inc. (NASDAQ:VYGR) PT at $13.39
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have received an average recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year […] - 2025-06-13 02:32:50
BNP Paribas Financial Markets Trims Stock Position in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
BNP Paribas Financial Markets decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 87.8% in the fourth quarter, Holdings Channel reports. The firm owned 6,025 shares of the company’s stock after selling 43,210 shares during the period. BNP Paribas Financial Markets’ holdings in Voyager Therapeutics were worth $34,000 at the end of […] - 2025-06-05 04:18:54
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Shares Sold by Deutsche Bank AG
Deutsche Bank AG trimmed its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 45.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 42,470 shares of the company’s stock after selling 35,898 shares during the period. Deutsche Bank AG’s holdings in Voyager Therapeutics were worth $241,000 at the end of the […] - 2025-06-02 04:42:59
State of Wyoming Trims Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
State of Wyoming decreased its position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 36.8% during the fourth quarter, Holdings Channel reports. The fund owned 8,904 shares of the company’s stock after selling 5,191 shares during the period. State of Wyoming’s holdings in Voyager Therapeutics were worth $50,000 as of its most recent filing […] - 2025-05-30 05:08:56
Man Group plc Purchases New Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Man Group plc acquired a new position in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 41,200 shares of the company’s stock, valued at approximately $234,000. Man Group plc owned 0.08% of Voyager Therapeutics […] - 2025-05-28 05:00:56
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $13.39 Consensus PT from Brokerages
Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) have earned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the company, MarketBeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average […] - 2025-05-19 02:32:50
Legal & General Group Plc Acquires 7,597 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Legal & General Group Plc lifted its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 65.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 19,245 shares of the company’s stock after buying an additional 7,597 shares during the period. Legal & General Group Plc’s holdings in Voyager Therapeutics were worth […] - 2025-05-02 04:30:49
XTX Topco Ltd Invests $178,000 in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
XTX Topco Ltd bought a new position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 31,375 shares of the company’s stock, valued at approximately $178,000. Other hedge funds have also recently modified their holdings of the company. Picton Mahoney Asset Management grew its […] - 2025-04-29 05:00:58
Wellington Management Group LLP Increases Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Wellington Management Group LLP raised its stake in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 13.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 261,251 shares of the company’s stock after acquiring an additional 31,882 shares during the […] - 2025-04-14 04:50:52
HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR)
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $30.00 price target on the stock. VYGR has been the subject of a number of other reports. StockNews.com cut shares of Voyager Therapeutics from a […] - 2025-04-10 02:58:47
Bank of New York Mellon Corp Cuts Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Bank of New York Mellon Corp lessened its holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 22.5% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 193,315 shares of the company’s stock after selling 56,213 shares during the period. Bank of New York Mellon Corp’s holdings […] - 2025-03-25 05:14:53
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $15.72 Average Price Target from Analysts
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price […] - 2025-03-05 04:20:51
Allspring Global Investments Holdings LLC Buys 7,573 Shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR)
Allspring Global Investments Holdings LLC boosted its position in shares of Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) by 23.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 39,313 shares of the company’s stock after acquiring an additional 7,573 shares during […] - 2025-02-26 06:42:54
Voyager Therapeutics (NASDAQ:VYGR) Receives “Outperform” Rating from Wedbush
Wedbush reiterated their outperform rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report published on Tuesday morning,RTT News reports. Wedbush currently has a $9.00 price target on the stock, down from their prior price target of $11.00. Several other brokerages have also recently issued reports on VYGR. Cantor Fitzgerald started coverage […] - 2025-02-12 07:14:56

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) VYGR holdings

DateNumber of VYGR Shares HeldBase Market Value of VYGR SharesLocal Market Value of VYGR SharesChange in VYGR Shares HeldChange in VYGR Base ValueCurrent Price per VYGR Share HeldPrevious Price per VYGR Share Held
2025-11-11 (Tuesday)33,058USD 140,827USD 140,8270USD 0 USD 4.26 USD 4.26
2025-11-10 (Monday)33,058VYGR holding increased by 88USD 140,827VYGR holding increased by 1364USD 140,82788USD 1,364 USD 4.26 USD 4.23
2025-11-07 (Friday)32,970USD 139,463VYGR holding increased by 330USD 139,4630USD 330 USD 4.23 USD 4.21999
2025-11-06 (Thursday)32,970VYGR holding increased by 88USD 139,133VYGR holding decreased by -1273USD 139,13388USD -1,273 USD 4.21999 USD 4.27
2025-11-05 (Wednesday)32,882USD 140,406VYGR holding increased by 3617USD 140,4060USD 3,617 USD 4.27 USD 4.16
2025-11-04 (Tuesday)32,882VYGR holding increased by 89USD 136,789VYGR holding decreased by -13731USD 136,78989USD -13,731 USD 4.16 USD 4.59
2025-11-03 (Monday)32,793USD 150,520VYGR holding decreased by -2623USD 150,5200USD -2,623 USD 4.59 USD 4.66999
2025-10-31 (Friday)32,793USD 153,143VYGR holding increased by 4919USD 153,1430USD 4,919 USD 4.66999 USD 4.51999
2025-10-30 (Thursday)32,793VYGR holding increased by 445USD 148,224VYGR holding decreased by -900USD 148,224445USD -900 USD 4.51999 USD 4.60999
2025-10-29 (Wednesday)32,348VYGR holding increased by 178USD 149,124VYGR holding decreased by -788USD 149,124178USD -788 USD 4.60999 USD 4.65999
2025-10-28 (Tuesday)32,170USD 149,912VYGR holding decreased by -4826USD 149,9120USD -4,826 USD 4.65999 USD 4.81001
2025-10-27 (Monday)32,170USD 154,738VYGR holding increased by 5147USD 154,7380USD 5,147 USD 4.81001 USD 4.65002
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VYGR by Blackrock for IE00BYXG2H39

Show aggregate share trades of VYGR

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY88 4.260* 4.30
2025-11-06BUY88 4.220* 4.30
2025-11-04BUY89 4.160* 4.30
2025-10-30BUY4454.6604.480 4.498USD 2,002 4.30
2025-10-29BUY1784.6104.725 4.713USD 839 4.29
2025-10-22SELL-3484.7704.990 4.968USD -1,729 4.28 Loss of -238 on sale
2025-10-20BUY1745.0705.120 5.115USD 890 4.28
2025-10-17BUY4334.9505.270 5.238USD 2,268 4.27
2025-10-15BUY6885.2905.380 5.371USD 3,695 4.27
2025-10-03BUY6164.8604.860 4.860USD 2,994 4.26
2025-10-02BUY884.7204.940 4.918USD 433 4.26
2025-09-30BUY1764.6704.730 4.724USD 831 4.25
2025-09-26BUY1764.5204.530 4.529USD 797 4.25
2025-09-25BUY1764.0904.200 4.189USD 737 4.25
2025-09-18BUY884.4904.560 4.553USD 401 4.25
2025-09-17BUY2644.2604.530 4.503USD 1,189 4.25
2025-08-20SELL-3523.3503.570 3.548USD -1,249 4.26 Profit of 252 on sale
2025-07-30BUY3483.4603.790 3.757USD 1,307 4.29
2025-07-17SELL-1763.2203.350 3.337USD -587 4.35 Profit of 179 on sale
2025-07-11SELL-7043.4903.620 3.607USD -2,539 4.38 Profit of 546 on sale
2025-07-07BUY2643.0403.200 3.184USD 841 4.41
2025-07-02BUY4,8403.2003.430 3.407USD 16,490 4.43
2025-06-11BUY1763.3803.630 3.605USD 634 4.50
2025-06-10BUY1763.4603.500 3.496USD 615 4.51
2025-06-04SELL-883.3203.510 3.491USD -307 4.55 Profit of 93 on sale
2025-04-23BUY883.4903.600 3.589USD 316 4.94
2025-04-10SELL-7042.9903.080 3.071USD -2,162 5.12 Profit of 1,441 on sale
2025-04-08SELL-882.8503.200 3.165USD -279 5.17 Profit of 176 on sale
2025-04-07SELL-883.0603.200 3.186USD -280 5.19 Profit of 176 on sale
2025-04-04SELL-4403.0903.200 3.189USD -1,403 5.22 Profit of 892 on sale
2025-04-01BUY3523.3703.460 3.451USD 1,215 5.26
2025-03-31SELL-2643.3803.740 3.704USD -978 5.28 Profit of 417 on sale
2025-03-14SELL-1,4083.9004.160 4.134USD -5,821 5.51 Profit of 1,934 on sale
2025-03-07SELL-1764.2604.320 4.314USD -759 5.61 Profit of 229 on sale
2025-03-04SELL-883.9604.000 3.996USD -352 5.69 Profit of 149 on sale
2025-02-25BUY1764.1204.200 4.192USD 738 5.83
2025-02-19SELL-884.3004.420 4.408USD -388 5.95 Profit of 135 on sale
2025-02-13BUY2644.3804.520 4.506USD 1,190 6.08
2025-02-12BUY884.4204.440 4.438USD 391 6.11
2025-02-11BUY3524.2105.200 5.101USD 1,796 6.15
2024-12-30SELL-4,6585.5905.730 5.716USD -26,625 6.42 Profit of 3,297 on sale
2024-11-18SELL-1,5155.3905.650 5.624USD -8,520 6.88 Profit of 1,896 on sale
2024-11-08SELL-1017.1307.200 7.193USD -726 6.86 Loss of -34 on sale
2024-10-21SELL-1027.6608.170 8.119USD -828 0.00 Loss of -828 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VYGR

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19134,0501,311312,52642.9%
2025-09-18117,0272,694296,37939.5%
2025-09-17165,0801,456371,36944.5%
2025-09-16194,8320353,91255.1%
2025-09-1589,2070184,69248.3%
2025-09-12203,6920480,75342.4%
2025-09-11147,8350471,40231.4%
2025-09-10135,3040359,69537.6%
2025-09-0997,880878266,63236.7%
2025-09-08174,291855410,09342.5%
2025-09-05204,8324,000670,46630.6%
2025-09-0495,1760318,86229.8%
2025-09-03106,4031,000319,62033.3%
2025-09-0287,1750390,14622.3%
2025-08-2923,709069,01134.4%
2025-08-2830,4790134,57622.6%
2025-08-2730,2460166,36618.2%
2025-08-2672,2820244,50729.6%
2025-08-25103,3072,700223,34646.3%
2025-08-2270,9070313,48022.6%
2025-08-2183,8010197,56442.4%
2025-08-2093,8510282,66433.2%
2025-08-19207,660401447,19446.4%
2025-08-1866,9240173,66338.5%
2025-08-15108,0030237,60445.5%
2025-08-1470,7410184,04538.4%
2025-08-13122,0640559,99021.8%
2025-08-12161,6681,382445,13636.3%
2025-08-1193,2060250,68537.2%
2025-08-08195,2158,750602,54432.4%
2025-08-07131,0406,440452,72528.9%
2025-08-06183,3760280,58565.4%
2025-08-05287,6664,519646,32944.5%
2025-08-04413,42330778,41453.1%
2025-08-01124,2932425,67129.2%
2025-07-31142,3810492,53728.9%
2025-07-30369,7098,850892,16941.4%
2025-07-29120,7442290,85341.5%
2025-07-2875,134886201,47637.3%
2025-07-2556,604142194,14329.2%
2025-07-2480,3240266,10230.2%
2025-07-2380,3190284,33628.2%
2025-07-2248,8080151,16832.3%
2025-07-2186,6251,853238,51936.3%
2025-07-18116,106125214,10954.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.